Partners Value Investments L.P.

Institutional investor · Portfolio as of Q2 2026

Q2 2026 biggest moves
  • DEODEO

    Diageo

    New

    0.5% of portfolio

2 changes in all

Top Holdings7 positions

Checking export access…
Activity:
BN

Brookfield Corporation

181.4M$7.7B78.9%$20.43+108.05%
12 qtrssince 2023-Q3
Unchanged
0
BAM

Brookfield Asset Management Inc

29.6M$1.3B13.5%$30.04+47.84%
12 qtrssince 2023-Q3
Unchanged
0
BNT

Brookfield Wealth Solutions Ltd.

12.3M$525.6M5.4%$35.05+21.49%
8 qtrssince 2024-Q3
Unchanged
0
BBUC

Brookfield Business Corporation

5.2M$153.9M1.6%$31.51-5.48%
2 qtrssince 2026-Q1
Decreased
0
DEO
DEO
ADR

Diageo plc

609,150$49M0.5%$79.350.00%
1 qtr
New
51
GOOG

Alphabet Inc.

22,500$7.9M0.1%$176.77+99.75%
5 qtrssince 2025-Q2
Unchanged
0
META

Meta Platforms, Inc.

11,619$6.5M0.1%$735.10-23.43%
5 qtrssince 2025-Q2
Unchanged
0
$9.8B
AUM
7
Positions
Q2 2026
Filing
HI rating · 4.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$8,398,563,393-8.92426461671%
2025-Q2$9,875,687,96117.5878242371%
2025-Q3$10,799,553,8619.35495231976%
2025-Q4$10,702,413,516-0.899484795856%
2026-Q1$9,344,597,344-12.6870090561%
2026-Q2$9,796,108,2714.83178579428%
Activity profile
$ moved · Q2'26
New82%Increased0%Decreased18%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q14%1-4Q14%1-2Y43%2Y+29%

Partners Value Investments L.P. manages $9.8B across 7 positions as of Q2 2026. Top holdings: BN (78.9%), BAM (13.5%), BNT (5.4%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4.5/5.0.

Top holdings by portfolio weight

Total AUM$10B
BN78.87%
BAM13.55%
BNT5.37%
BBUC1.57%
DEO0.50%
GOOG0.08%
META0.07%

Portfolio allocation by GICS sector

Sectors3
Financial Services99.34%
Consumer Defensive0.51%
Communication Services0.15%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(4.5 / 5.0)
Holdings P&L66
Conviction66
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used